Results 171 to 180 of about 13,245 (221)
Some of the next articles are maybe not open access.

Minimal thyroid ophthalmopathy

Neurology, 1987
We studied six patients with the clinical, sonographic, CT, and biochemical profile of minimal euthyroid Graves' disease (MEGD). This syndrome was characterized clinically by small but obtrusive and measurable amounts of diplopia related to endocrine ophthalmopathy and the conspicuous absence of systemic or laboratory signs of thyrotoxicosis ...
R H, Spector, J A, Carlisle
openaire   +2 more sources

Inducing Graves’ ophthalmopathy

Journal of Endocrinological Investigation, 2004
The majority of patients with Graves' disease (GD) have some degree of ocular involvement and this requires surgical or medical intervention in about 5% of cases. There are autoimmune and inflammatory processes operating in Graves' ophthalmopathy (GO), which together induce glycosaminoglycan production, edema and adipogenesis resulting in an increase ...
M, Ludgate, G, Baker
openaire   +2 more sources

Graves ophthalmopathy

Current Opinion in Ophthalmology, 2001
Graves ophthalmopathy (GO) is an autoimmune disease that typically affects the thyroid gland and the orbit. The roles of the thyroid stimulating hormone receptor and cellular and humoral immunity in the pathogenesis of GO are being investigated. Investigators are gaining insights into the epidemiology of GO as it relates to other ocular and autoimmune ...
openaire   +2 more sources

Graves' ophthalmopathy

Medical Clinics of North America, 1995
Graves' ophthalmopathy is an organ-specific autoimmune process strongly linked to Graves' hyperthyroidism. Although the hyperthyroidism can be successfully treated, it is often the ophthalmopathy that produces the greatest long-term disability for patients suffering from this disease.
openaire   +2 more sources

IMMUNOGENETICS OF GRAVES' OPHTHALMOPATHY

Clinical Endocrinology, 1988
SUMMARYWe have performed an immunogenetic analysis of 53 patients with severe Graves' ophthalmopathy, 51 patients with Graves' disease but little or no clinically apparent eye disease, and 90 controls. The distribution of restriction fragment length polymorphisms was analysed in the three groups, using probes for the HLA‐DQα and DRβ regions, the T‐cell
A P, Weetman   +5 more
openaire   +2 more sources

Prevention of Graves’ ophthalmopathy

Best Practice & Research Clinical Endocrinology & Metabolism, 2012
Smoking is the most important risk factor for the occurrence/progression of Graves' ophthalmopathy (GO), as well as for its lower/slower response to immunosuppression. Accordingly, refrain from smoking should be urged, both as primary prevention (removal of risk factors in Graves' patients without GO), secondary prevention (early detection and ...
openaire   +3 more sources

Massage Gun Ophthalmopathy

Ophthalmology, 2023
Michael I, Seider, Cindy S, Hwang
openaire   +2 more sources

[Paraneoplastic ophthalmopathies].

Journal francais d'ophtalmologie, 2022
Ocular paraneoplastic syndromes are rare conditions that can affect any part of the eye at any age. Thus, every ophthalmologist should be familiar with their management, as some of them may reveal severe, life-threatening conditions. These consist overwhelmingly of neuro-ophthalmological manifestations, affecting the optic nerve (paraneoplastic optic ...
Z, Böcskei   +4 more
openaire   +1 more source

Euthyroid Graves’ ophthalmopathy

QJM: An International Journal of Medicine, 2023
A Schattner   +3 more
openaire   +2 more sources

Thyroid ophthalmopathy.

Minerva endocrinologica, 2006
Thyroid associated ophthalmopathy (TAO) is an inflammatory orbital disease of autoimmune origin with the potential to cause severe functional and psychosocial effects. It presents one of the most difficult challenges in the clinical practice of ophthalmology. Pathogenesis of the disease is not yet fully understood. It is usually associated with thyroid
J, Levy   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy